We become the sales and marketing arm for a market you haven’t entered yet.

You keep focus on the core. We test an adjacent market, score the unit economics, and sell it. We build none of the product, and there is no cost to you.

Name a market

The gap

The problem

A lot of companies that raised in 2022 and 2023 have a product that works, and a valuation that current revenue can’t support. Sales and marketing for an adjacent market doesn’t get funded, even when the product could work there. The team just can’t afford to find out.

The work

How it works

You name an adjacency. We test demand, score the unit economics, and only then sell into it.

  1. Name an adjacency

    Tell us one market you would go after if sales and marketing were funded.

  2. We test demand

    We put up landing pages and look for real buyer signal before anyone commits.

  3. We score it

    We measure the adjacency against unit economics, not just interest.

  4. We sell it

    If it holds up, we get on a call and become the sales and marketing arm for that market.

When the right path is public sector, we can work those channels too, including SAM registration and reseller relationships. That’s a lead source, not the core of what we do.

The terms

How deals can be structured

There is no up-front cost to the company. The structure follows the market and the relationship.

White label

Your product, offered under a different brand in the new market.

Field-of-use carve-out

Rights limited to a defined use or customer set, so your core stays yours.

Royalty or revenue share

We’re paid from revenue the adjacency generates.

Equity that vests based on revenue brought in

Ownership that vests as we bring in revenue.

The founder side

Why it’s low risk for the founder

You don’t build product, you don’t fund the test, and you don’t take a meeting until the market shows signal.

No product work

We build none of the product.

No burn

There’s no cost to you to test and sell into the adjacency.

Upside only

Our interest is tied to revenue brought in, through the deal structure we agree on.

You stay on the core

We take the adjacency so you can keep focus where it already is.

The people

Who’s behind it

Matt Gardner, Rish Mehta, and Dustin Crump.

The name is our initials.

FAQ

Questions we get

What does MRD Ventures do?

We become the sales and marketing arm for an adjacent market a company has not entered yet. We do not build product. The founder stays focused on the core business, and we put up the go-to-market effort.

Do you build product?

No. We build none of the product. We test demand, score the market, and sell into it.

How are deals structured?

It depends on the company and the market. Structures we use include white label, a field-of-use carve-out, a royalty or revenue share, or equity that vests based on revenue we bring in. There is no cost to the company up front.

Who is it for?

Founders and CEOs, especially at companies that raised in 2022 and 2023, who have a product that works and an adjacent market they would enter if sales and marketing were funded.

Is there a cost to work with you?

There is no cost to the company for us to test and sell into the adjacency. Our upside comes from the deal structure, not from a fee you pay to get started.

How do I start?

Send a note to info@rmdvc.com with one adjacent market you would go after if sales and marketing were funded. We test demand and score the economics before anyone gets on a call.